Your shopping cart is currently empty

Anti-virulence factor-IN-3 (Compound 21) is a covalent β-amino sulfone inhibitor of anthrax edema factor (EF), with a Ki of 0.44 μM. It produces an active vinyl sulfone intermediate that forms an irreversible covalent bond with the Lys residue at the EF active site, permanently inhibiting the adenylate cyclase activity of EF. Anti-virulence factor-IN-3 effectively suppresses EF-induced cAMP production, with an EC50 of 0.15 μM, and can be used in the study of anthrax infection.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Anti-virulence factor-IN-3 (Compound 21) is a covalent β-amino sulfone inhibitor of anthrax edema factor (EF), with a Ki of 0.44 μM. It produces an active vinyl sulfone intermediate that forms an irreversible covalent bond with the Lys residue at the EF active site, permanently inhibiting the adenylate cyclase activity of EF. Anti-virulence factor-IN-3 effectively suppresses EF-induced cAMP production, with an EC50 of 0.15 μM, and can be used in the study of anthrax infection. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.